lncRNA, mRNA, ESWL,PCNL,SBF2-AS1, FENDRR-19, NLRP3.
Showing 51 - 75 of >10,000
Vaccination; Infection, COVID-19 Trial (Comirnaty)
Not yet recruiting
- Vaccination; Infection
- COVID-19
- Comirnaty
- (no location specified)
Aug 4, 2023
SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)
Not yet recruiting
- SARS-CoV2 Infection
- Coronavirus Infection
- mRNA- COVID-19
- Prevnar13
-
Hamilton, Ontario, CanadaMcMaster University
Jun 29, 2022
Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)
Recruiting
- Pneumococcal Infection
- V110
- +4 more
-
North Hollywood, California
- +45 more
Aug 11, 2022
Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated
Not yet recruiting
- HCC
- No intervention was required for patients or control group in this study
- (no location specified)
Apr 21, 2023
Outcome of Myocarditis After COVID-19 mRNA Vaccine
Completed
- Myocarditis
- data collection in healthcare professionals with COVID-19 mRNA vaccine booster
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Cardiology
Jun 29, 2022
COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)
Active, not recruiting
- COVID-19
- Breakthrough Infection
- BNT162b2
- +2 more
-
Taoyuan city, TaiwanChang Gung Memorial Hospital
Jul 21, 2022
Pain, Lithiasis Trial (Quadratus lumborum block type III, Erector spinae plane block)
Not yet recruiting
- Pain
- Lithiasis
- Quadratus lumborum block type III
- Erector spinae plane block
- (no location specified)
Jul 8, 2023
Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)
Not yet recruiting
- Depressive Disorder
- Fluoxetine 20 mg
- +2 more
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 19, 2023
COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),
Not yet recruiting
- COVID-19
- +4 more
- Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
- Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
- (no location specified)
Sep 29, 2023
Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent Trial in Worldwide (Givosiran, Placebo)
Completed
- Acute Hepatic Porphyria
- +6 more
- Givosiran
- Placebo
-
Little Rock, Arkansas
- +35 more
May 31, 2022
COVID-19 Trial (Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector), Bivalent Recombinant COVID-19 Vaccine
Not yet recruiting
- COVID-19
- Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector)
- +2 more
- (no location specified)
Jul 5, 2022
Tamsulosin, Extracorporeal Shock Wave Lithotripsy, Stone, Kidney Trial in Mansoura (Tamsulosin, Placebo)
Active, not recruiting
- Tamsulosin
- +4 more
- Tamsulosin
- Placebo
-
Mansoura, EgyptUrology and Nephrology Center
Mar 8, 2023
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Urolithiasis Trial in Seoul (Electroconductive and Electrohydraulic types)
Completed
- Urolithiasis
- Electroconductive and Electrohydraulic types
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 20, 2023
Percutaneous Nephrolithotomy Trial in Hengyang (one-handed technique)
Recruiting
- Percutaneous Nephrolithotomy
- one-handed technique
-
Hengyang, Hunan, ChinaThe First Affiliated Hospital of University of South China
Jan 30, 2023
Cancer Trial in Anderlecht (Spikevax, Comirnaty)
Recruiting
- Cancer
- Spikevax
- Comirnaty
-
Anderlecht, Belgium
- +1 more
Aug 30, 2022
COVID-19 Breakthrough Infection in Fully Vaccinated People and
Enrolling by invitation
- COVID-19 Pneumonia
- COVID-19
- Pfizer COVID-19 mRNA vaccine
- Moderna COVID-19 mRNA vaccine
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
Diabetes, Type 2 Trial in Basel (Dapansutrile, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Dapansutrile
- Placebo
-
Basel, SwitzerlandUniversity Hospital Basel
Sep 21, 2023
COVID-19 Trial in Hong Kong (BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell), WIBP Omicron Inactivated COVID-19 vaccine
Recruiting
- COVID-19
- BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell)
- +2 more
-
Hong Kong, Hong KongQueen Mary Hospital
May 27, 2022
lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially
Completed
- Potentially Malignant Lesions, Oral Lichen Planus, Leukoplakia
- Real-time Polymerase Chain Reaction technique
-
Fayoum, EgyptFayoum University
Feb 7, 2023
COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)
Recruiting
- COVID-19 Vaccines
- MVA-SARS-2-ST
-
Hannover, GermanyHannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022
Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,
Active, not recruiting
- Immunogenicity
- +2 more
- SW-BIC-213;SARS-Cov-2.
- +2 more
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Jan 8, 2023
SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
- Saline solution
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Feb 26, 2023
Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among
Completed
- SARS-CoV-2
-
New York, New YorkAetion Inc.
May 5, 2022
Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)
Completed
- Healthy
- Chronic Stable Illness
- casirivimab+imdevimab
- Moderna mRNA-1273 vaccine
-
Little Rock, Arkansas
- +5 more
Jan 9, 2023